Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kathy Miller
South San Francisco, California, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
TCG Labs-Soleil forms and oversees portfolio companies dedicated to single-asset biologic programs from ideation to clinical proof of concept, focusing on transformative medicines, especially in biologics and antibody engineering. No disclosed clinical-stage results.
- Therapeutic areas
- CardiovascularImmunologyOphthalmologyNeurologyOncology
- Modalities
- BiologicAntibodyMonoclonal antibodyProtein
- Industry
- Investors
02
Partnerships
The Column Group (venture fund)Portfolio partnerships with independent biotech companies
Beyond the preview
Go deeper on Kathy Miller.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kathy Miller.